Interaction of heparins with fibroblast growth factors : Conformational aspectsGUERRINI, Marco; HRICOVINI, Milos; TORRI, Giangiacomo et al.Current pharmaceutical design. 2007, Vol 13, Num 20, pp 2045-2056, issn 1381-6128, 12 p.Article

Combined quantitative ¹H and ¹³C nuclear magnetic resonance spectroscopy for characterization of heparin preparationsGUERRINI, Marco; BISIO, Antonella; TORRI, Giangiacomo et al.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, pp 473-482, issn 0094-6176Article

Structural and conformational aspects of the anticoagulant and antithrombotic activity of heparin and dermatan sulfate : Heparin and heparinoids: Correlation between structure and antithrombotic activity. Clinical applications and future perspectivesCASU, Benito; GUERRINI, Marco; TORRI, Giangiacomo et al.Current pharmaceutical design. 2004, Vol 10, Num 9, pp 939-949, issn 1381-6128, 11 p.Article

How To Find a Needle (or Anything Else) in a Haystack: Two-Dimensional Correlation Spectroscopy-Filtering with Iterative Random Sampling Applied to Pharmaceutical HeparinRUDD, Timothy R; MACCHI, Eleonora; GARDINI, Cristina et al.Analytical chemistry (Washington). 2012, Vol 84, Num 15, pp 6941-6947, issn 0003-2700, 7 p.Article

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsGUERRINI, Marco; BECCATI, Daniela; AL-HAKIM, Ali et al.Nature biotechnology (Print). 2008, Vol 26, Num 6, pp 669-675, issn 1087-0156, 7 p.Article

Monosaccharide composition of glycans based on Q-HSQC NMRLANZI SASSAKI, Guilherme; GUERRINI, Marco; VASSOLER SERRATO, Rodrigo et al.Carbohydrate polymers. 2014, Vol 104, pp 34-41, issn 0144-8617, 8 p.Article

Low-Molecular-Weight Heparins: Differential Characterization/Physical CharacterizationGUERRINI, Marco; BISIO, Antonella.Handbook of experimental pharmacology. 2012, Vol 207, pp 127-157, issn 0171-2004, 31 p.Article

The Tainted Heparin Story: An UpdateGUERRINI, Marco; SHRIVER, Zachary; BISIO, Antonella et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 907-911, issn 0340-6245, 5 p.Conference Paper

Construction and use of a library of bona fide heparins employing ¹H NMR and multivariate analysisRUDD, Timothy R; GAUDESI, Davide; SKIDMORE, Mark A et al.Analyst (London. 1877. Print). 2011, Vol 136, Num 7, pp 1380-1389, issn 0003-2654, 10 p.Article

Structure of a heteroxylan of gum exudate of the palm Scheelea phalerata (uricuri)SIMAS, Fernanda F; GORIN, Philip A. J; GUERRINI, Marco et al.Phytochemistry. 2004, Vol 65, Num 16, pp 2347-2355, issn 0031-9422, 9 p.Article

Cycloartane and oleanane saponins from Egyptian Astragalus spp. as modulators of lymphocyte proliferationVEROTTA, Luisella; GUERRINI, Marco; EL-SEBAKHY, Nadia A et al.Planta medica. 2002, Vol 68, Num 11, pp 986-994, issn 0032-0943, 9 p.Article

A robust method to quantify low molecular weight contaminants in heparin: detection of tris(2-n-butoxyethyl) phosphateSASSAKI, Guilherme L; RITER, Daniel S; YATES, Edwin A et al.Analyst (London. 1877. Print). 2011, Vol 136, Num 11, pp 2330-2338, issn 0003-2654, 9 p.Article

Undersulfated and glycol-split heparins endowed with antiangiogenic activityCASU, Benito; GUERRINI, Marco; PENCO, Sergio et al.Journal of medicinal chemistry (Print). 2004, Vol 47, Num 4, pp 838-848, issn 0022-2623, 11 p.Article

Structural features of low-molecular-weight heparins affecting their affinity to antithrombinBISIO, Antonella; VECCHIETTI, Davide; CITTERIO, Laura et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 865-873, issn 0340-6245, 9 p.Conference Paper

Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solutionHRICOVINI, Milos; GUERRINI, Marco; BISIO, Antonella et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 325-334, issn 0094-6176Article

Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivativeHARENBERG, Job; CASU, Benito; GUERRINI, Marco et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 4, pp 343-354, issn 0094-6176Article

In vitro antiplasmodial activity of extracts of Tristaniopsis species and identification of the active constituents : Ellagic acid and 3,4,5-trimethoxyphenyl-(6'-O-galloyl)-O-β-D-glucopyranosideVEROTTA, Luisella; DELL'AGLI, Mario; GIOLITO, Andrea et al.Journal of natural products (Print). 2001, Vol 64, Num 5, pp 603-607, issn 0163-3864Article

High-sensitivity visualisation of contaminants in heparin samples by spectral filtering of ¹H NMR spectraRUDD, Timothy R; GAUDESI, Davide; LIMA, Marcelo A et al.Analyst (London. 1877. Print). 2011, Vol 136, Num 7, pp 1390-1398, issn 0003-2654, 9 p.Article

Low-molecular-weight heparin from Cu²⁺ and Fe²⁺ Fenton type depolymerisation processesVISMARA, Elena; PIERINI, Monica; MASCELLANI, Giuseppe et al.Thrombosis and haemostasis. 2010, Vol 103, Num 3, pp 613-622, issn 0340-6245, 10 p.Article

Low molecular weight heparins : Structural differentiation by bidimensional nuclear magnetic resonance spectroscopyGUERRINI, Marco; GUGLIERI, Sara; NAGGI, Annamaria et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 478-487, issn 0094-6176, 10 p.Conference Paper

Cycloartane saponins from Astragalus peregrinus as modulators of lymphocyte proliferationVEROTTA, Luisella; GUERRINI, Marco; EL-SEBAKHY, N. A et al.Fitoterapia (Milano). 2001, Vol 72, Num 8, pp 894-905, issn 0367-326XArticle

Preserving the original heparin structure of a novel low molecular weight heparin by γ-irradiationBISIO, Antonella; DE AMBROSI, Luigi; GONELLA, Sergio et al.Arzneimittel-Forschung. 2001, Vol 51, Num 10, pp 806-813, issn 0004-4172Article